Pediatric NUT Carcinoma Is a Rare and Challenging Tumor: Single Center Experience of Five Children

Oncologist. 2019 Nov;24(11):e1232-e1235. doi: 10.1634/theoncologist.2019-0358. Epub 2019 Sep 5.

Abstract

Background: Nuclear protein of the testis (NUT) carcinoma is a rare and aggressive malignancy associated with rearrangements of the nuclear protein of the testis (NUT) gene on chromosome 15q14. Because of its rarity, this tumor is often underdiagnosed and underreported, and there is limited literature regarding its biology and optimal management.

Methods and results: We report our experience of five patients with pediatric NUT carcinoma, all of whom presented with midline head and neck mass. In spite of aggressive multimodality treatment, only one patient survives.

Conclusion: NUT carcinoma has a dismal prognosis in spite of aggressive multimodality management (surgery and adjuvant chemotherapy and/or radiation). Novel strategies are required to improve outcomes of patients with this tumor.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / therapy
  • Child
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Proteins
  • Nuclear Proteins / metabolism*
  • Oncogene Proteins / metabolism*
  • Prognosis
  • Retrospective Studies
  • Young Adult

Substances

  • NUTM1 protein, human
  • Neoplasm Proteins
  • Nuclear Proteins
  • Oncogene Proteins